Genmab A (GMAB) Total Current Liabilities (2023 - 2026)
Genmab A's Total Current Liabilities came in at $1.14 billion for the quarter ended Jun 30, 2026, down 3.2% from the prior quarter.
Powered by 
Analysis
Genmab A (GMAB) Total Current Liabilities (2023 - 2026) Analysis & Trends
As of Dec 31, 2025, Genmab A's Total Current Liabilities was $1.43 billion, up 91.8% from the prior year.
- Total Current Liabilities has increased in each of the last three years, with a five-year compound annual growth rate of 57.9% (years ended Dec 2020 to Dec 2025).
- Going back by year, Total Current Liabilities was $744 million in the year ended Dec 31, 2024 (+102.2%), $368 million in the year ended Dec 31, 2023 (+116.3%), $170.12 million in the year ended Dec 31, 2022 (-4.0%) and $177.18 million in the year ended Dec 31, 2021 (+21.7%).
- The five-year range for quarterly Total Current Liabilities is $129.26 million (the quarter ended Sep 30, 2025) to $1.43 billion (the quarter ended Dec 31, 2025).
- Year-over-year, Total Current Liabilities increased in three of the last four quarters, with growth averaging 78.7%.
- The fastest year-over-year change in Total Current Liabilities over five years came in the quarter ended Dec 31, 2024 (growth of 263.4%), and the weakest in the quarter ended Sep 30, 2021 (a decline of 90.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 47.74 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 54.90 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 41.64 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 27.73 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 31.75 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 31.55 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 25.50 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.02 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 32.65 Bn |
| 10 | Genmab A | 2.56 Bn | -2.81 Bn | 1.07 Bn | 1.14 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Bn |
| Mar 31, 2026 | 1.18 Bn |
| Dec 31, 2025 | 1.43 Bn |
| Sep 30, 2025 | 741.00 Mn |
| Jun 30, 2025 | 629.00 Mn |
| Dec 31, 2024 | 744.00 Mn |
| Dec 31, 2023 | 368.00 Mn |
| Jan 1, 2023 | 260.00 Mn |
API Access
Genmab A Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=GMAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();